Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
17.63
+0.24 (1.38%)
At close: Jun 26, 2026, 4:00 PM EDT
17.62
-0.01 (-0.06%)
After-hours: Jun 26, 2026, 5:08 PM EDT
Theravance Biopharma Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Theravance Biopharma stock has a consensus rating of "Buy" and an average price target of $17.4. The average 1-year stock price forecast is 1.30% lower than the current stock price, while the lowest is $15 (-14.92%) and the highest is $21 (+19.12%).
Price Target: $17.4 (-1.30%)
Analyst Consensus: Buy
* Price targets were last updated on May 28, 2026.
Analyst Ratings
The average analyst rating for Theravance Biopharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $18 → $19 | Buy | Reiterates | $18 → $19 | +7.77% | May 28, 2026 |
| BTIG | BTIG | Buy Maintains $21 | Buy | Maintains | $21 | +19.12% | May 8, 2026 |
| TD Cowen | TD Cowen | Hold Reiterates $15 | Hold | Reiterates | $15 | -14.92% | May 8, 2026 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | -3.57% | Apr 7, 2026 |
| Oppenheimer | Oppenheimer | Hold Downgrades $27 → $14 | Hold | Downgrades | $27 → $14 | -22.46% | Mar 5, 2026 |
Financial Forecast
Revenue This Year
84.13M
from 107.46M
Decreased by -21.71%
Revenue Next Year
96.83M
from 84.13M
Increased by 15.09%
EPS This Year
0.21
from -0.15
EPS Next Year
1.26
from 0.21
Increased by 497.62%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 93.7M | ||
| Avg | 84.1M | ||
| Low | 77.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -12.8% | ||
| Avg | -21.7% | ||
| Low | -28.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.21 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |